MIRAMAR, Fla., Sept. 16, 2026 /PRNewswire/ -- DifGen Pharmaceuticals LLC ("DifGen"), a US based specialty generic pharmaceutical company, today announced that the U.S. Food and Drug Administration ...
Drs. Haydon DuMond, Mehul Desai, and Shirish Ingawale examine research findings and regulatory precedents demonstrating that ...
A nationwide voluntary recall involving compounded GLP-1 injections has been issued over concerns about sterility, prompting ...